TNF and carcinoma: Discovering novel treatments to lower the likelihood of recurrent AP progressing to CP and then to carcinoma changes may be possible by measuring DNA damage and inflammatory markers and determining the clinical scenario from the time of AP development. TNF-α and its receptors are crucial players in the emergence of acinar cell death in this paradigm because TNF-α triggers apoptosis, and NF- kB gets activated.